Literature DB >> 17245434

PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.

Richard Fox1, Thomas Q Nhan, G Lynn Law, David R Morris, W Conrad Liles, Stephen M Schwartz.   

Abstract

Rho-associated kinases (ROCKs) are critical molecules involved in the physiological functions of macrophages, such as chemotaxis and phagocytosis. We demonstrate that macrophage adherence promotes rapid changes in physiological functions that depend on translational upregulation of preformed ROCK-1 mRNA, but not ROCK-2 mRNA. Before adherence, both ROCK mRNAs were present in the cytoplasm of macrophages, whereas ROCK proteins were undetectable. Macrophage adherence promoted signaling through P-selectin glycoprotein ligand-1 (PSGL-1)/Akt/mTOR that resulted in synthesis of ROCK-1, but not ROCK-2. Following synthesis, ROCK-1 was catalytically active. In addition, there was a rapamycin/sirolimus-sensitive enhanced loading of ribosomes on preformed ROCK-1 mRNAs. Inhibition of mTOR by rapamycin abolished ROCK-1 synthesis in macrophages resulting in an inhibition of chemotaxis and phagocytosis. Macrophages from PSGL-1-deficient mice recapitulated pharmacological inhibitor studies. These results indicate that receptor-mediated regulation at the level of translation is a component of a rapid set of mechanisms required to direct the macrophage phenotype upon adherence and suggest a mechanism for the immunosuppressive and anti-inflammatory effects of rapamycin/sirolimus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245434      PMCID: PMC1783463          DOI: 10.1038/sj.emboj.7601522

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  76 in total

Review 1.  Upstream open reading frames as regulators of mRNA translation.

Authors:  D R Morris; A P Geballe
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

Authors:  C G Groth; L Bäckman; J M Morales; R Calne; H Kreis; P Lang; J L Touraine; K Claesson; J M Campistol; D Durand; L Wramner; C Brattström; B Charpentier
Journal:  Transplantation       Date:  1999-04-15       Impact factor: 4.939

3.  Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.

Authors:  C Godson; S Mitchell; K Harvey; N A Petasis; N Hogg; H R Brady
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 4.  Role of caspases in death and survival of the plaque macrophage.

Authors:  Thomas Q Nhan; W Conrad Liles; Stephen M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

5.  Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

Authors:  M Maekawa; T Ishizaki; S Boku; N Watanabe; A Fujita; A Iwamatsu; T Obinata; K Ohashi; K Mizuno; S Narumiya
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

6.  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.

Authors:  A V Somlyo; D Bradshaw; S Ramos; C Murphy; C E Myers; A P Somlyo
Journal:  Biochem Biophys Res Commun       Date:  2000-03-24       Impact factor: 3.575

7.  Release kinetics and cell trafficking in relation to bacterial growth explain the time course of blood neutrophils and monocytes during primary Salmonella infection.

Authors:  Katsuhisa Takumi; Johan Garssen; Rob de Jonge; Wim de Jong; Arie Havelaar
Journal:  Int Immunol       Date:  2004-11-29       Impact factor: 4.823

8.  Rho-associated kinase modulates myocardial inflammatory cytokine responses.

Authors:  Jureta W Horton; David L Maass; Cherry Ballard-Croft
Journal:  Shock       Date:  2005-07       Impact factor: 3.454

9.  Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII.

Authors:  Manuel Martinez; Magali Joffraud; Sylvain Giraud; Bénédicte Baïsse; Michael Pierre Bernimoulin; Marc Schapira; Olivier Spertini
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

10.  Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner.

Authors:  Michael Sebbagh; Jocelyne Hamelin; Jacques Bertoglio; Eric Solary; Jacqueline Bréard
Journal:  J Exp Med       Date:  2005-02-07       Impact factor: 14.307

View more
  28 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 2.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

3.  E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling.

Authors:  Tadayuki Yago; Bojing Shao; Jonathan J Miner; Longbiao Yao; Arkadiusz G Klopocki; Kenichiro Maeda; K Mark Coggeshall; Rodger P McEver
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

4.  mTORC2 Signaling Selectively Regulates the Generation and Function of Tissue-Resident Peritoneal Macrophages.

Authors:  Min-Hee Oh; Samuel L Collins; Im-Hong Sun; Ada J Tam; Chirag H Patel; Matthew L Arwood; Yee Chan-Li; Jonathan D Powell; Maureen R Horton
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

5.  P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice.

Authors:  Wei Luo; Hui Wang; Miina K Ohman; Chiao Guo; Kate Shi; Julia Wang; Daniel T Eitzman
Journal:  Atherosclerosis       Date:  2011-10-17       Impact factor: 5.162

6.  Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells.

Authors:  Edy Y Kim; Hadas Ner-Gaon; Jack Varon; Aidan M Cullen; Jingyu Guo; Jiyoung Choi; Diana Barragan-Bradford; Angelica Higuera; Mayra Pinilla-Vera; Samuel Ap Short; Antonio Arciniegas-Rubio; Tomoyoshi Tamura; David E Leaf; Rebecca M Baron; Tal Shay; Michael B Brenner
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 7.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

Review 8.  Rho kinase: an important mediator of atherosclerosis and vascular disease.

Authors:  Qian Zhou; James K Liao
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.

Authors:  William E Braun; Jesse D Schold; Brian R Stephany; Rita A Spirko; Brian R Herts
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

10.  Quantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium.

Authors:  Cheng-Kang Chiang; Aleksander Tworak; Brian M Kevany; Bo Xu; Janice Mayne; Zhibin Ning; Daniel Figeys; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2017-10-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.